Atrium Therapeutics

RNA · NASDAQ

$7.98+$0.37 (+4.86%)TodayMarket closed ·
Prev close $7.61

Who owns RNA

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 42.3% of RNA’s shares.

  • Sessa Capital8.8%
  • T. Rowe Price Associates, Inc.8.3%
  • BlackRock Institutional Trust Company, N.A.6.3%
  • Vanguard Capital Management, LLC4.3%
  • Next 6 largest institutions14.7%
  • All other shareholders57.7%
Top institutional holders of RNA
HolderShares% of shares
Sessa Capital1.50M8.77%
T. Rowe Price Associates, Inc.1.43M8.33%
BlackRock Institutional Trust Company, N.A.1.07M6.27%
Vanguard Capital Management, LLC730.83K4.27%
CRCM L.P.641.54K3.75%
TIG Advisors, L.L.C.561.53K3.28%
Geode Capital Management, L.L.C.386.93K2.26%
Two Sigma Investments, LP345.48K2.02%
683 Capital Management LLC300.00K1.75%
BlackRock Financial Management, Inc.274.73K1.61%

Largest mutual fund holders

Top mutual fund holders of RNA
HolderShares% of shares
T. Rowe Price Health Sciences Fund566.43K3.31%
Vanguard Total Stock Market Index Fund518.42K3.03%
T. Rowe Price New Horizons Fund443.26K2.59%
iShares Russell 2000 ETF375.72K2.20%
Vanguard Extended Market Index Fund188.63K1.10%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of RNA in the last 6 months.

Latest RNA insider transactions
InsiderTypeSharesValue
Younis HusamTax withholding11.22K$100.38K
Kenney StephanieTax withholding2.38K$21.26K
Winslow Brendan R.Tax withholding6.74K$60.34K
Hoyos Rocio MartinTax withholding8.32K$74.46K
Gallagher Kathleen P.Tax withholding11.63K$104.11K
Flanagan W. MichaelTax withholding22.81K$204.17K
Hughes Steven GeorgeTax withholding21.46K$192.06K
Boyce SarahTax withholding126.42K$1.13M

Short interest

Settled Sep 30, 2026

Shares short
3.40M
Days to cover
8.27
% of shares outstanding
19.85%
Average daily volume
410.85K
Change since last report
−0.1%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.